Emvision Medical Devices Ltd (EMV) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.301x

Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has a cash flow conversion efficiency ratio of -0.301x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.94 Million ≈ $-4.20 Million USD) by net assets (AU$19.74 Million ≈ $13.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Emvision Medical Devices Ltd (EMV) liquidity interval to measure how many days the company can operate on defensive assets alone.

Emvision Medical Devices Ltd - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Emvision Medical Devices Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Emvision Medical Devices Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emvision Medical Devices Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Poongwon Precision Co. Ltd.
KQ:371950
-0.270x
Ester Industries Limited
NSE:ESTER
0.033x
Climb Global Solutions
NASDAQ:CLMB
-0.102x
Singha Estate Public Company Limited
BK:S
0.022x
KOMPLETT ASA NK -40
F:GJ60
-0.308x
Tait Marketing & Distribution Co Ltd
TWO:5902
0.062x
Nien Hsing Textile Co Ltd
TW:1451
0.022x
CastleNet Technology
TWO:8059
-0.066x

Annual Cash Flow Conversion Efficiency for Emvision Medical Devices Ltd (2018–2025)

The table below shows the annual cash flow conversion efficiency of Emvision Medical Devices Ltd from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Emvision Medical Devices Ltd (EMV) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$9.28 Million
≈ $6.57 Million
AU$-7.84 Million
≈ $-5.54 Million
-0.844x -160.85%
2024-06-30 AU$18.52 Million
≈ $13.10 Million
AU$-5.99 Million
≈ $-4.24 Million
-0.324x -298.43%
2023-06-30 AU$5.12 Million
≈ $3.62 Million
AU$834.15K
≈ $590.22K
0.163x +130.53%
2022-06-30 AU$7.08 Million
≈ $5.01 Million
AU$-3.78 Million
≈ $-2.68 Million
-0.534x -19.47%
2021-06-30 AU$10.05 Million
≈ $7.11 Million
AU$-4.49 Million
≈ $-3.18 Million
-0.447x +24.14%
2020-06-30 AU$5.52 Million
≈ $3.91 Million
AU$-3.26 Million
≈ $-2.30 Million
-0.589x -22.46%
2019-06-30 AU$4.60 Million
≈ $3.26 Million
AU$-2.22 Million
≈ $-1.57 Million
-0.481x +9.42%
2018-06-30 AU$1.28 Million
≈ $905.05K
AU$-679.59K
≈ $-480.85K
-0.531x --

About Emvision Medical Devices Ltd

AU:EMV Australia Medical Devices
Market Cap
$104.56 Million
AU$147.77 Million AUD
Market Cap Rank
#19084 Global
#616 in Australia
Share Price
AU$1.59
Change (1 day)
+5.30%
52-Week Range
AU$1.51 - AU$2.37
All Time High
AU$4.13
About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more